vs
GRAHAM CORP（GHM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是GRAHAM CORP的1.2倍（$69.8M vs $56.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.0%，领先379.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 20.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.5%）
格雷厄姆控股公司是一家多元化的美国控股集团，总部位于弗吉尼亚州阿灵顿县，在特拉华州注册成立，该集团曾是《华盛顿邮报》与《新闻周刊》杂志的所有者。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
GHM vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$56.7M
营收增速更快
RIGL
高出0.6%
20.5%
净利率更高
RIGL
高出379.0%
5.0%
两年增速更快
RIGL
近两年复合增速
7.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.7M | $69.8M |
| 净利润 | $2.8M | $268.1M |
| 毛利率 | 23.8% | 91.5% |
| 营业利润率 | 5.5% | 33.2% |
| 净利率 | 5.0% | 384.0% |
| 营收同比 | 20.5% | 21.2% |
| 净利润同比 | 79.2% | 1769.2% |
| 每股收益（稀释后） | $0.25 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GHMRIGL
| Q4 25 | $56.7M | $69.8M | ||
| Q3 25 | $66.0M | $69.5M | ||
| Q2 25 | $55.5M | $101.7M | ||
| Q1 25 | $59.3M | $53.3M | ||
| Q4 24 | $47.0M | $57.6M | ||
| Q3 24 | $53.6M | $55.3M | ||
| Q2 24 | $50.0M | $36.8M | ||
| Q1 24 | $49.1M | $29.5M |
净利润GHMRIGL
| Q4 25 | $2.8M | $268.1M | ||
| Q3 25 | $3.1M | $27.9M | ||
| Q2 25 | $4.6M | $59.6M | ||
| Q1 25 | $4.4M | $11.4M | ||
| Q4 24 | $1.6M | $14.3M | ||
| Q3 24 | $3.3M | $12.4M | ||
| Q2 24 | $3.0M | $-1.0M | ||
| Q1 24 | $1.3M | $-8.2M |
毛利率GHMRIGL
| Q4 25 | 23.8% | 91.5% | ||
| Q3 25 | 21.7% | 93.2% | ||
| Q2 25 | 26.5% | 95.6% | ||
| Q1 25 | 27.0% | 91.7% | ||
| Q4 24 | 24.8% | 89.9% | ||
| Q3 24 | 23.9% | 85.5% | ||
| Q2 24 | 24.8% | 92.4% | ||
| Q1 24 | 25.9% | 93.1% |
营业利润率GHMRIGL
| Q4 25 | 5.5% | 33.2% | ||
| Q3 25 | 6.5% | 40.9% | ||
| Q2 25 | 8.9% | 60.1% | ||
| Q1 25 | 9.3% | 23.9% | ||
| Q4 24 | 4.7% | 28.9% | ||
| Q3 24 | 7.9% | 25.4% | ||
| Q2 24 | 6.5% | 1.2% | ||
| Q1 24 | 3.1% | -23.6% |
净利率GHMRIGL
| Q4 25 | 5.0% | 384.0% | ||
| Q3 25 | 4.7% | 40.2% | ||
| Q2 25 | 8.3% | 58.6% | ||
| Q1 25 | 7.4% | 21.5% | ||
| Q4 24 | 3.4% | 24.9% | ||
| Q3 24 | 6.1% | 22.5% | ||
| Q2 24 | 5.9% | -2.8% | ||
| Q1 24 | 2.7% | -27.9% |
每股收益（稀释后）GHMRIGL
| Q4 25 | $0.25 | $14.11 | ||
| Q3 25 | $0.28 | $1.46 | ||
| Q2 25 | $0.42 | $3.28 | ||
| Q1 25 | $0.40 | $0.63 | ||
| Q4 24 | $0.14 | $0.82 | ||
| Q3 24 | $0.30 | $0.70 | ||
| Q2 24 | $0.27 | $-0.06 | ||
| Q1 24 | $0.11 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $131.3M | $391.5M |
| 总资产 | $292.9M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资GHMRIGL
| Q4 25 | $22.3M | $155.0M | ||
| Q3 25 | $20.6M | $137.1M | ||
| Q2 25 | $10.8M | $108.4M | ||
| Q1 25 | $21.6M | $77.1M | ||
| Q4 24 | $30.0M | $77.3M | ||
| Q3 24 | $32.3M | $61.1M | ||
| Q2 24 | $21.6M | $49.1M | ||
| Q1 24 | $16.9M | $49.5M |
总债务GHMRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益GHMRIGL
| Q4 25 | $131.3M | $391.5M | ||
| Q3 25 | $127.6M | $117.6M | ||
| Q2 25 | $123.4M | $81.9M | ||
| Q1 25 | $119.6M | $18.6M | ||
| Q4 24 | $114.4M | $3.3M | ||
| Q3 24 | $112.5M | $-14.6M | ||
| Q2 24 | $108.2M | $-29.9M | ||
| Q1 24 | $105.6M | $-31.7M |
总资产GHMRIGL
| Q4 25 | $292.9M | $513.6M | ||
| Q3 25 | $287.0M | $242.5M | ||
| Q2 25 | $252.3M | $206.7M | ||
| Q1 25 | $264.1M | $176.0M | ||
| Q4 24 | $264.3M | $164.0M | ||
| Q3 24 | $249.5M | $139.4M | ||
| Q2 24 | $244.2M | $128.4M | ||
| Q1 24 | $233.9M | $126.5M |
负债/权益比GHMRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $2.4M | — |
| 自由现金流率自由现金流/营收 | 4.3% | — |
| 资本支出强度资本支出/营收 | 4.1% | — |
| 现金转化率经营现金流/净利润 | 1.67× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-6.1M | — |
8季度趋势，按日历期对齐
经营现金流GHMRIGL
| Q4 25 | $4.8M | $22.0M | ||
| Q3 25 | $13.6M | $24.0M | ||
| Q2 25 | $-2.3M | $30.5M | ||
| Q1 25 | $-3.6M | $-893.0K | ||
| Q4 24 | $5.2M | $14.5M | ||
| Q3 24 | $13.9M | $21.7M | ||
| Q2 24 | $8.7M | $302.0K | ||
| Q1 24 | $8.6M | $-5.0M |
自由现金流GHMRIGL
| Q4 25 | $2.4M | — | ||
| Q3 25 | $9.4M | — | ||
| Q2 25 | $-9.3M | — | ||
| Q1 25 | $-8.7M | — | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $5.7M | — | ||
| Q1 24 | $4.6M | — |
自由现金流率GHMRIGL
| Q4 25 | 4.3% | — | ||
| Q3 25 | 14.3% | — | ||
| Q2 25 | -16.7% | — | ||
| Q1 25 | -14.7% | — | ||
| Q4 24 | -4.5% | — | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 11.5% | — | ||
| Q1 24 | 9.4% | — |
资本支出强度GHMRIGL
| Q4 25 | 4.1% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 12.6% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 15.6% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 8.2% | — |
现金转化率GHMRIGL
| Q4 25 | 1.67× | 0.08× | ||
| Q3 25 | 4.40× | 0.86× | ||
| Q2 25 | -0.49× | 0.51× | ||
| Q1 25 | -0.81× | -0.08× | ||
| Q4 24 | 3.29× | 1.01× | ||
| Q3 24 | 4.25× | 1.75× | ||
| Q2 24 | 2.94× | — | ||
| Q1 24 | 6.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
RIGL
暂无分部数据
